Credit Suisse Ag Singular Genomics Systems, Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$1.82 - $2.71 $576 - $859
-317 Reduced 99.37%
2 $0
Q3 2022

Nov 10, 2022
BUY
$2.5 - $4.73 $667 - $1,262
267 Added 513.46%
319 $1,000
Q2 2022

Aug 12, 2022
BUY
$2.86 - $6.44 $148 - $334
52 New
52 $0

Others Institutions Holding OMIC

# of Institutions
2
Shares Held
1.43M
Call Options Held
0
Put Options Held
0
View Full List

About Singular Genomics Systems, Inc.

OMIC Quotes by TradingView
  • Ticker OMIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 71,193,296
  • Market Cap $1.41B
  • Description
  • Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...
More about OMIC
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email